Geron | GERN - Assets

Stock Price
1.94
Daily Change
0.17 9.60%
Monthly
41.61%
Yearly
-18.14%
Q1 Forecast
1.82

Geron reported $567.38M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Amgen USD 90.59B 445M Dec/2025
Bio Techne USD 2.52B 3.45M Dec/2025
Cassava Sciences USD 129.73M 5.65M Sep/2025
Cytokinetics USD 1.44B 210.92M Sep/2025
Esperion Therapeutics USD 364.02M 16.93M Sep/2025
Exelixis USD 2.84B 20.87M Dec/2025
Genmab DKK 6.46B 122M Jun/2025
Geron USD 567.38M 12.18M Sep/2025
Gilead Sciences USD 59.02B 490M Dec/2025
Incyte USD 6.96B 627.62M Dec/2025
MacroGenics USD 270.76M 25.34M Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Novavax USD 1.18B 156.66M Sep/2025